News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Nancy Mannix, JD

Articles by Nancy Mannix, JD

Which innovations can improve measurement, technology, investment, and public policy surrounding brain health?

Telling Humanity’s Brain Story: Insights From Brain Capital

ByHarris A. Eyre, MD, PhD,Robert M. Lundin, BSc, MBBCh,Shuo Chen, JD,Ryan Abbott, MD, JD, PhD,Shekhar Saxena, MD,Stephen T. C. Wong, PhD,James T. Hackett,William Hynes, DPhil,Daniela Schiller, PhD,Nancy Mannix, JD,Serena Jenkins, PhD,Claire Neihaus, MSc,Walter D. Dawson, DPhil,Michael Berk, MD, PhD

January 19th 2023

Which innovations can improve measurement, technology, investment, and public policy surrounding brain health?

Latest Updated Articles

Telling Humanity’s Brain Story: Insights From Brain Capital
Published: January 19th 2023 | Updated:

Trending on Psychiatric Times

Evidence-Based Psychotherapy and Psychopharmacology for Mood Disorders: A Conversation With Holly A. Swartz, MD

Can the Initial Antipsychotic Influence Years of Weight Gain?

New Post-Hoc Analysis: Ingrezza 40 mg Leads to Clinically Meaningful Improvements in Tardive Dyskinesia Symptoms

Reflections on Developments in Correctional Psychiatry, with Tony Tamburello, MD

Accessory to War

© 2025 MJH Life Sciences^®

All rights reserved.